The purpose of this book is to develop a hypothetical dossier based on regulations and guidances which are required to be followed when an actual submission is filed to the USFDA, with an objective to meet the Common Technical Document(CTD) requirements. For this purpose, Budesonide Dry Powder Inhaler(DPI) is selected as a product to prepare a hypothetical dossier. In terms of volume by 2026 it is expected that requirement of DPI in USA would be increased and may reach up to 400 million units per year due to increasing air pollution and increased rate of respiratory diseases in children as well as old age people. In this study an ANDA has been prepared which includes data of the different modules such as Module 1: Administrative Information, Module 2: Quality Overall Summary, Module 3: Quality (Drug substance and Drug product) and Module 5: Clinical Study Reports. To get the ANDA approval, generic applicants has to show scientific evidence that their product is bioequivalent to the innovators drug product. Once the application is submitted it will undergo through a thorough review process by CDER, OGD & OCP and if they find it satisfactory, product will get approval from FDA.
"Sinopsis" puede pertenecer a otra edición de este libro.
Sus derechos de garantía legal: Todos los consumidores de la UE se benefician de al menos dos años de protección de garantía legal para cualquier bien de consumo que se venda en la UE. Ver más
Librería: Redux Books, Grand Rapids, MI, Estados Unidos de America
Paperback. Condición: As New. Paperback. Cover shows very minor shelving wear, otherwise an unblemished copy.; 100% Satisfaction Guaranteed! Ships same or next business day! Nº de ref. del artículo: 132608270049
Cantidad disponible: 1 disponibles
Librería: Chiron Media, Wallingford, Reino Unido
PF. Condición: New. This item is printed on demand. Brand new book, sourced directly from publisher. Dispatch time is 6-7 days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely. Nº de ref. del artículo: 6666-IUK-9786200080943
Cantidad disponible: 20 disponibles
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Condición: New. Nº de ref. del artículo: 42069454-n
Cantidad disponible: Más de 20 disponibles
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de America
PAP. Condición: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Nº de ref. del artículo: L0-9786200080943
Cantidad disponible: Más de 20 disponibles
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
PAP. Condición: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Nº de ref. del artículo: L0-9786200080943
Cantidad disponible: Más de 20 disponibles
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Condición: As New. Unread book in perfect condition. Nº de ref. del artículo: 42069454
Cantidad disponible: Más de 20 disponibles
Librería: California Books, Miami, FL, Estados Unidos de America
Condición: New. Nº de ref. del artículo: I-9786200080943
Cantidad disponible: Más de 20 disponibles
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Condición: New. In English. Nº de ref. del artículo: ria9786200080943_new
Cantidad disponible: Más de 20 disponibles
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
Condición: New. Nº de ref. del artículo: 42069454-n
Cantidad disponible: Más de 20 disponibles
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The purpose of this book is to develop a hypothetical dossier based on regulations and guidances which are required to be followed when an actual submission is filed to the USFDA, with an objective to meet the Common Technical Document(CTD) requirements. For this purpose, Budesonide Dry Powder Inhaler(DPI) is selected as a product to prepare a hypothetical dossier. In terms of volume by 2026 it is expected that requirement of DPI in USA would be increased and may reach up to 400 million units per year due to increasing air pollution and increased rate of respiratory diseases in children as well as old age people. In this study an ANDA has been prepared which includes data of the different modules such as Module 1: Administrative Information, Module 2: Quality Overall Summary, Module 3: Quality (Drug substance and Drug product) and Module 5: Clinical Study Reports. To get the ANDA approval, generic applicants has to show scientific evidence that their product is bioequivalent to the innovators drug product. Once the application is submitted it will undergo through a thorough review process by CDER, OGD & OCP and if they find it satisfactory, product will get approval from FDA. 136 pp. Englisch. Nº de ref. del artículo: 9786200080943
Cantidad disponible: 2 disponibles